Where CSF Kappa Free Light Chains is reported
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Multiple Sclerosis | ↑ elevated | patients with other neurological inflammatory disorders and non-inflammatory diseases | — | Vecchio et al. 2024 |
Frequently asked questions
In which conditions is CSF Kappa Free Light Chains altered?
In the OSMF atlas CSF Kappa Free Light Chains is reported in Multiple Sclerosis. It is elevated in 1 across 1 entries.
Is there a standard clinical test for CSF Kappa Free Light Chains?
The atlas entries for CSF Kappa Free Light Chains do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal CSF Kappa Free Light Chains result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.